Energy News / Shareholders Foundation, Inc.

NASDAQ:ABEO Investor Alert: Investigation over Possible Wrongdoing at Abeona Therapeutics Inc

Via: ReleaseWire

Updated 12:00 PM CST, Tue, January 09,2018

An investigation for investors in Abeona Therapeutics Inc (NASDAQ:ABEO) shares over potential securities laws violations was announced.

San Diego, CA -- (SBWIRE) -- 01/09/2018 -- An investigation was announced for investors of Abeona Therapeutics Inc (NASDAQ:ABEO) shares over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Abeona Therapeutics Inc (NASDAQ:ABEO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain Abeona Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.

Dalas, TX based Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. Abeona Therapeutics Inc reported that its annual Total Revenue declined from $1.04 million in 2015 to $0.89 million in 2016 and that its Net Loss increased from $14.53 million in 2015 to $21.87 million in 2016.

On January 8, 2018, NASDAQ:ABEO shares closed at $15.25 per share.

Those who purchased shares of Abeona Therapeutics Inc (NASDAQ:ABEO), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqabeo-investor-alert-investigation-over-possible-wrongdoing-at-abeona-therapeutics-inc-913165.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com